Commentary on Hassenzahl's 'The effect of uncertainty on "risk rationalizing" decisions'

Journal of Risk Research

Volumn 8, Issue 2, 2005, Pages 139-143

  Tengs, Tammy O ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS; DECISION MAKING; RISK ASSESSMENT;

COST-EFFECTIVENESS ESTIMATES; INVESTMENT DECISIONS; RISK RATIONALIZING DECISION;

UNCERTAIN SYSTEMS;

EID: 32144461057     PISSN: 13669877     EISSN: None     Source Type: Journal    
DOI: 10.1080/1366987042000192390     Document Type: Review

References (19)

1. Baltussen, R. M., Hutubessy, R. C., Evans, D. B. and Murray, C. J. (2002) Uncertainty in costeffectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables, International Journal of Technology Assessment in Health Care 18, 112-19.
2. Briggs, A. H. (2000) Handling uncertainty in cost-effectiveness models, Pharmacoeconomics 17, 479-500.
3. Briggs, A. H., O'Brien, B. J. and Blackhouse, G. (2002) Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies, Annual Review of Public Health 23, 377-401.
4. Craig, B. A., Black, M. A. and Sendi, P. P. (2000) Uncertainty in decision models analyzing costeffectiveness, Medical Decision Making 20, 135-37.
5. Fenwick, E., Claxton, K. and Sculpher, M. (2001) Representing uncertainty: the role of costeffectiveness acceptability curves, Health Economics 10, 779-87.
6. Graham, J. D. (2003) Smarter regulation - progress and unfinished business'. Speech given at the Kennedy School of Government, Harvard University, Cambridge Massachusetts, 25 September, Available at: http://www.whitehouse.gov/ omb/inforeg/speeches/030925graham.html. Accessed on 10 October 2003.
7. Hassenzahl, D. (2005) The effect of uncertainty on 'risk rationalizing' decisions, Journal of Risk Research 8(2), 119-138.
8. Heinzerling, L. (2002) Five-hundred life-saving interventions and their misuse in the debate over regulatory reform, Risk: Health, Safety and Environment 13, 151-75.
9. Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, A. M. and Weissert, W. G. (2000) Willingness to pay for a quality-adjusted year: in search of a standard, Medical Decision Making 20, 332-42.
10. Hunink, M. G., Bult, J. R., de Vries, J. and Weinstein, M. C. (1998) Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental cost and effectiveness evaluated with an nonparametric bootstrap method, Medical Decision Making 18, 337-46.
11. Kishimoto, A. (1997) A comparative analysis of cost-effectiveness of risk reduction policies in Japan, Japanese Journal of Risk Analysis 8, 165-73.
12. Parker, R. W. (2003) Grading the government, Available at: http://papers.ssrn.com/so13/ papers.cfm?abstract_id=370321. Accessed on 10 October 2003.
13. Parmigiani, G., Samsa, G. P., Ancukiewicz, M., Lipcomb, J., Hasselblad, V. and Matchar, D. B. (1997) Assessing uncertainty in cost-effectiveness analysis: application to a complex decision model, Medical Decision Making 17, 390-401.
14. Ramsberg, J. A. L. and Sjoberg, L. (1997) The cost-effectiveness of lifesaving interventions in Sweden, Risk Analysis 17, 467-78.
15. Stinnett, A. A. and Mullahy, J. (1998) Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis, Medical Decision Making 18, S68-S80.
16. Tengs, T. and Graham, J. (1996) The opportunity costs of haphazard societal investments in life saving, In R. Hahn (ed) Risks, Costs, and Lives Saved: Getting Better Results from Regulation, pp. 162-82. New York: Oxford University Press.
17. Tengs, T. and Berry, D. (2000) The cost-effectiveness of testing for the BRCA1 and BRCA2 breastovarian cancer susceptibility genes, Disease Management and Clinical Outcomes 1, 15-24.
18. Tengs, T., Adams, M., Pliskin, J., Safran, D., Siegel, J., Weinstein, M. and Graham, J. (1995) Five-hundred life-saving interventions and their cost-effectiveness, Risk Analysis 15, 369-90.
19. Tengs, T., Osgood, N. and Chen, L. (2001) The cost-effectiveness of intensive national school-based anti-tobacco education: results from the Tobacco Policy Model, Preventive Medicine 33, 558-70.